Ole Isacson, MD, PhD, recently served as Chief Scientific Officer of Pfizer’s Neuroscience Research Unit in Cambridge, MA. Dr. Isacson is professor of Neurology and Neuroscience at Harvard Medical School as well as principal faculty of the Harvard Stem Cell Institute, and was the founding director of the Neuroregeneration Research Institute at McLean Hospital. Dr. Isacson received his medical bachelor and doctor of medicine (as a full PhD doctoral degree and training in medical neurobiology) from the University of Lund in Sweden. His postdoctoral fellowship and training were at Cambridge University, England. Dr. Isacson is a member of several editorial boards and previously served as Editor-in-Chief of Molecular and Cellular Neuroscience. He is a member of The Michael J Fox Foundation Scientific Advisory Board and was selected to serve as a member of the FDA Cellular, Tissue and Gene Therapies Advisory Committee for 2014-2018. In 2014, he was elected fellow of the American Association for the Advancement of Science (AAAS) for his Parkinson’s disease research. He has published over 350 scientific articles and has received several awards for this work.